Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +37.38%
#3 Glidr Glidr +35.94%
#4 Walrus Walrus +22.68%
#5 Tutorial Tutorial +22.05%
#6 Codatta Codatta +16.69%
#7 Humanity Humanity +16.02%
#8 Ribbita by Virtuals Ribbita by Virtuals +14.73%
#9 Enso Enso +14.41%
#10 Cysic Cysic +12.50%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Quantum Genomics S.A. Quantum Genomics S.A.

Quantum Genomics S.A.

ALQGC
Rank in Stocks #37063
Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France,... Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France, in 2005, focuses on creating treatments for cardiovascular ailments. Its therapeutic approach utilizes the brain aminopeptidase A inhibition (BAPAI) platform, primarily addressing high blood pressure (hypertension) and heart failure. The company's key asset, firibastat, is currently undergoing a crucial Phase III study as a standalone therapy for hypertension and is also in clinical trials for heart failure. Additionally, Quantum Genomics is progressing QGC011 for hypertension in combination therapy, and further developing QGC006 and QGC606 to target both hypertension and heart failure.
Share Price
$0.07600875
Last synced: 2024-11-20
Market Cap
$2.06M
Change (1 day)
-0.51%
Change (1 year)
0.00%
Country
FR
Trade Quantum Genomics S.A. (ALQGC)

Category

Healthcare
Operating Margin for Quantum Genomics S.A. (ALQGC)
Operating Margin as of August 2026 TTM: -14,728,350.00%
According to Quantum Genomics S.A. latest financial reports and stock price the company's current Operating Margin (TTM) is -14,728,350.00%. At the end of 2023 the company had an Operating Margin of -15,847.92%.
Operating Margin history for Quantum Genomics S.A. from 2009 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -14,728,350.00% 0.00%
2024 -14,728,350.00% 92,835.54%
2023 -15,847.92% 1,224.94%
2022 -1,196.12% 86.62%
2021 -640.95% -30.35%
2020 -920.28% 32.31%
2019 -695.54% -99.81%
2018 -368,912.10% 0.00%
2017 0.00% 0.00%
2016 0.00% -100.00%
2015 -2,990.22% 301.12%
2014 -745.46% -93.18%
2013 -10,934.16% 97.88%
2012 -5,525.72% -14.48%
2011 -6,461.44% -10.42%
2010 -7,212.81% -3.54%
2009 -7,477.55% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -100.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -100.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00% -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
31.23% -100.00%
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.